Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TNFRSF21 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
mRNA | GBAS | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | CACTIN | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
mRNA | ENDOD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | IZUMO1R | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | FHDC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | HES2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | PRRC2A | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | ATP1B3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | ADAMTS6 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |